Senior insider sale
PMV PHARMACEUTICALS, INC. — senior position signals high conviction
$2.42M
1.50M shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 1.50M shares of PMV PHARMACEUTICALS, INC. valued at approximately $2.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/23/2025ACC: 0000947871-25-000922
Director10% Owner
Since Sep 2020
1.50M
Shares to sell
$2.42M
Approx. market value
1M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Initial Public Offering
Cash
9/29/2020
1MTotal acquired1M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/29/2020 | Initial Public Offering Cash | 1M | — |
| Total | 1M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
500K
Market value
$900.0K
9/10/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
1M
Market value
$1.52M
10/23/2025
Total
Units
1.50M
Value
$2.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/10/2025 | 500K | $900.0K | — | Completed |
| Planned — Approximate Date | ||||
10/23/2025 | 1M | $1.52M | Nasdaq Stock Market | Planned |
| Total | 1.50M | $2.42M | ||